Patent Assignment
Reel/Frame 007183/0670
Merger
Recorded: 1994-10-28
Pages: 13
Assignor
WHITBY RESEARCH, INC.
Executed: 1994-09-26
Assignee
DISCOVERY THERAPEUTICS, INC.
2028 DABNEY ROAD, SUITE E-17, RICHMOND, VIRGINIA, 23230-3311
Covered Properties
(71)
Title Not Available
Application:
05/588,247 →
Penetration Enhancers for Transdermal Drug Delivery of Systemic Agents
Patent:
4,405,616 →
Application:
06/380,161 →
Penetration Enhancers for Transdermal Drug Delivery of Systemic Agents
Patent:
4,562,075 →
Application:
06/517,131 →
Dopamine Agonists and Use Thereof
Patent:
4,540,691 →
Application:
06/600,008 →
Substituted 2-Aminotetralins
Patent:
4,564,628 →
Application:
06/640,685 →
Tamper-Resistant Packaging Tape
Patent:
4,652,473 →
Application:
06/679,763 →
N6-Substituted-5'-(N-Substituted Carboxamido)Adenosines as Cardiac Vasodilators and Antihypertensive Agents
Patent:
5,310,731 →
Application:
06/742,565 →
Method and Compositions for Reducing the Intraocular Pressure of Mammals
Patent:
4,657,925 →
Application:
06/811,768 →
Vehicle Composition Containing 1-Substituted Azacycloalkan-2-Ones
Patent:
5,108,991 →
Application:
06/815,251 →
N-6 Substituted Adenosine Derivatives as Cardiac Vasodilators
Patent:
5,043,325 →
Application:
06/829,285 →
1,4-Dihydropyridines
Patent:
4,849,436 →
Application:
06/838,536 →
Substituted 2-Aminotetralins
Patent:
4,722,933 →
Application:
06/839,976 →
Lactam Formation by a Selective Cyclization Process
Patent:
4,870,173 →
Application:
06/847,464 →
Novel Compounds and Use Thereof in Selective Cyclization Process
Patent:
4,880,924 →
Application:
06/847,639 →
Compositions Comprising 1-Substituted Azacycloalkenes
Patent:
4,755,535 →
Application:
06/855,497 →
Substituted 2-Aminotetralins
Patent:
4,743,618 →
Application:
06/891,262 →
Compositions Comprising N,N-Dialkylalkanamides
Patent:
4,902,676 →
Application:
06/912,947 →
Penetration Enhancers for Transdermal Delivery of Systemic Agents
Patent:
4,801,586 →
Application:
06/916,403 →
Penetration Enhancers for Transdermal Delivery of Systemic Agents
Patent:
4,808,414 →
Application:
06/932,651 →
Penetration Enhancers for Transdermal Delivery of Systemic Agents
Patent:
4,917,896 →
Application:
06/932,709 →
1,4-Dihydropyridines
Patent:
4,833,150 →
Application:
07/002,008 →
Method for Treating Schizophrenia
Patent:
4,882,352 →
Application:
07/047,882 →
Compositions Comprising 1-Substituted Azacycloalkanes and Their Uses
Patent:
4,886,545 →
Application:
07/098,028 →
Compositions Comprising 1-Oxo- or Thiohydrocarbyl Substituted Azacycloaklkanes
Patent:
4,920,101 →
Application:
07/103,445 →
Penetration Enhancers for Transdermal Delivery of Systemic Agent
Patent:
4,879,275 →
Application:
07/199,454 →
Penetration Enhancers for Transdermal Delivery of Systemic Agents
Patent:
4,996,199 →
Application:
07/199,801 →
Method and Compositions for Treatment of Parkinsonism Syndrome in Mammals
Patent:
4,885,308 →
Application:
07/206,193 →
Method for Detecting Dopaminergic Diseases Using Fluorine-18 Radiolabelled D2 Dopamine Receptor Ligands
Patent:
4,931,270 →
Application:
07/216,405 →
Penetration Enhancers for Transdermal Delivery of Systemic Agents
Patent:
4,886,783 →
Application:
07/233,551 →
Methods for Administration Using 1-Substituted Azacycloalkanes
Patent:
5,034,386 →
Application:
07/233,553 →
Compositions Comprising 1-Oxohydrocarbyl-Substituted Azacyclohexanes
Patent:
5,073,544 →
Application:
07/327,763 →
Compositions Comprising 1-Substituted Azacycloalkanes
Patent:
4,992,422 →
Application:
07/341,320 →
Selective Cyclization Process
Patent:
4,965,371 →
Application:
07/357,027 →
Method and Compositions for Treatment of Parkinsonism Syndrome in Mammels
Patent:
4,996,226 →
Application:
07/397,749 →
N6-Substituted 9-Methyladenines: a New Class of Adenosine Receptor Antagonists
Patent:
5,066,655 →
Application:
07/424,293 →
Compositions Comprising 1-Substituted Azacycloalkanes
Patent:
5,043,441 →
Application:
07/467,891 →
Penetration Enhancers for Transdermal Delivery of Systemic Agents
Patent:
5,142,044 →
Application:
07/467,892 →
Penetration Enhancers for Transdermal Delivery of Systemic Agents
Patent:
5,118,845 →
Application:
07/467,894 →
2-Aralkoxy and 2-Alkoxy Adenosine Derivatives as Coronary Vasodilators and Antihypertensive Agents
Patent:
5,140,015 →
Application:
07/482,282 →
Antidepressant Agents
Patent:
5,093,352 →
Application:
07/524,584 →
Penetration Enhancers for Transdermal Delivery of Systemic Agents
Patent:
5,204,339 →
Application:
07/563,863 →
Method of Determining Viability of Tissue
Patent:
5,117,830 →
Application:
07/610,544 →
Penetration Enhancers for Transdermal Delivery of Systemic Agents
Patent:
5,118,676 →
Application:
07/611,600 →
Compositions Comprising 1-Substituted Azacycloalkanes
Patent:
5,256,647 →
Application:
07/611,612 →
Penetration Enhancers for Transdermal Delivery of Systemic Agents
Patent:
5,234,959 →
Application:
07/611,613 →
Penetration Enhances for Transdermal Delivery of Systemic Agents
Patent:
5,118,692 →
Application:
07/625,189 →
Method of Producing Body Weight and Food Intake Using a Dopamine D2 Receptor Agonist
Patent:
5,234,945 →
Application:
07/641,221 →
Topical Compositions Useful as Skin Penetration Barriers
Application:
07/673,016 →
2-Aryl Substituted N-Acetyltryptamines and Procss of Preparine Such
Patent:
5,283,343 →
Application:
07/718,342 →
N-Substituted Thiolactams
Patent:
5,218,113 →
Application:
07/745,721 →
Substituted 2-Aminotetralins
Patent:
5,177,112 →
Application:
07/757,336 →
Substituted 2-Aminotetralins Useful as Dopaminergics
Patent:
5,118,704 →
Application:
07/758,887 →
Method for Treating Schizophrenia
Patent:
5,268,385 →
Application:
07/793,848 →
Compounds Useful as Antiproliferative Agents
Patent:
5,206,377 →
Application:
07/802,723 →
Composition for Determining Viability of Tissue
Patent:
5,256,398 →
Application:
07/828,115 →
Substituted 2-Aminotetralins
Patent:
5,274,003 →
Application:
07/837,229 →
2-Hydrazoadenosines and Their Utility for the Treatment of Vascular Conditions
Patent:
5,278,150 →
Application:
07/873,440 →
Substituted 2-Aminotetralins and Pharmaceutical Use
Patent:
5,256,661 →
Application:
07/951,993 →
Penetration Enhancers for Transdermal Delivery of Systemic Agents
Patent:
5,270,346 →
Application:
07/973,239 →
Compounds Useful as Antiproliferative Agents
Patent:
5,314,908 →
Application:
07/977,455 →
Penetration Enhancers for Transdermal Delivery of Systemic Agents
Application:
07/989,434 →
N6-Substituted 9-Methyladenines: a New Class of Adenosine Receptor Antagonists
Application:
08/073,916 →
2-Aralkoxy and 2-Alkoxy Adenosine Derivatives as Coronary Vasodilators and Antihypertensive Agents
Patent:
36,494 →
Application:
08/098,180 →
Topical Compositions Useful as Skin Penetration Barriers
Patent:
6,086,905 →
Application:
08/102,176 →
Transdermal Penetration Enhancers
Patent:
5,472,946 →
Application:
08/103,504 →
N6-Substituted 9-Methyladenines: a New Class of Adenosine Receptor Antagonists
Application:
08/118,898 →
Diagnostic Uses of Hydrazinoadenosines
Patent:
5,477,857 →
Application:
08/119,774 →
Substituted 2-Aminotetralins
Patent:
5,358,971 →
Application:
08/131,845 →
Penetration Enhancers for Transdermal Delivery of Systemic Agents
Patent:
5,470,848 →
Application:
08/139,684 →
Substituted 2-Aminotetralins
Patent:
5,430,056 →
Application:
08/200,338 →
Compounds Useful as Anxiolytic, Sedative, and Hypnotic Agents
Application:
08/210,862 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest.
May 20, 1982
From: RAJADHYAKSHA, VITHAL J.
To: NELSON RESEARCH & DEVELOPMENT COMPANY, A CORP. OF CA
Reel/Frame 004001/0397 →
Assignment of Assignors Interest.
May 9, 1984
From: HORN, ALAN S.
To: NELSON RESEARCH & DEVELOPMEHT CO 19732 MACARTHUR BLVD CENTERPOINTE IRVINE CA 92715
Reel/Frame 004253/0507 →
Assignment of Assignors Interest.
Oct 9, 1984
From: HORN, ALAN S.
To: NELSON RESEARCH AND DEVELOPMENT COMPANY, CENTERPOINTE
Reel/Frame 004311/0914 →
Assignment of Assignors Interest.
Dec 10, 1984
From: HAN, HAK-RHIM
To: MINNESOTA MINING AND MANUFACTURING COMPANY
Reel/Frame 004344/0895 →
Assignment of Assignors Interest.
Jun 12, 1985
From: OLSSON, RAY A.; THOMPSON, ROBERT D.
To: NELSON RESEARCH
Reel/Frame 004415/0139 →
Assignment of Assignors Interest.
Feb 24, 1986
From: HORN, ALAN S.
To: NELSON RESEARCH & DEVELOPMENT CO., 1001 HEALTH SCIENCES ROAD WEST, IRVINE, CA. 92715 A CORP. OF CA.
Reel/Frame 004553/0663 →
Assignment of Assignors Interest.
Mar 11, 1986
From: MINASKANIAN, GEVORK
To: NELSON RESEARCH & DEVELOPMENT CO., A CORP OF CALIFORNIA
Reel/Frame 004542/0518 →
Assignment of Assignors Interest.
Apr 23, 1986
From: MINASKANIAN, GEVORK; PECK, JAMES V.
To: NELSON RESEARCH & DEVELOPMENT CO.
Reel/Frame 004548/0555 →
Assignment of Assignors Interest.
May 12, 1986
From: HORN, ALAN S.
To: NELSON RESEARCH & DEVELOPMENT CO.
Reel/Frame 004551/0510 →
Assignment of Assignors Interest.
May 29, 1986
From: MINASKANIAN, GEVORK; PECK, JAMES V.
To: NELSON RESEARCH & DEVELOPMENT CO.
Reel/Frame 004552/0116 →
Assignment of Assignors Interest.
Jun 20, 1986
From: PECK, JAMES V.; MINASKANIAN, GEVORK
To: NELSON RESEARCH & DEVELOPMENT CO., A CA. COMPANY
Reel/Frame 004570/0995 →
Assignment of Assignors Interest.
Jul 28, 1986
From: HORN, ALAN S.
To: NELSON RESEARCH & DEVELOPMENT CO., 1001 HEALTH SCIENCES ROAD WEST IRVINE, CA. 92715 A CORP. OF CA.
Reel/Frame 004605/0515 →
Assignment of Assignors Interest.
Oct 7, 1986
From: MINASKANIAN, GEVORK; PECK, JAMES V.
To: NELSON RESEARCH & DEVELOPMENT CO., A COMPANY OF VA.
Reel/Frame 004616/0678 →
Assignment of Assignors Interest.
Nov 19, 1986
From: PECK, JAMES V.; MINASKANIAN, GEVORK
To: NELSON RESEARCH & DEVELOPMENT CO.
Reel/Frame 004631/0167 →
Assignment of Assignors Interest.
Nov 19, 1986
From: PECK, JAMES V.; MINASKANIAN, GEVORK
To: NELSON RESEARCH & DEVELOPMENT CO.
Reel/Frame 004631/0093 →
Assignment of Assignors Interest.
Jul 23, 1987
From: PECK, JAMES V.; MINASKANIAN, GEVORK
To: NELSON RSEARCH AND DEVELOPMENT COMPANY, 1001 HEALTH SCIENCES ROAD WEST, IRVINE, CALIFORNIA 92715, A CA CORP.
Reel/Frame 004791/0880 →
Assignment of Assignors Interest.
Sep 30, 1987
From: MINASKANIAN, GEVORK; PECK, JAMES V.
To: NELSON RESEARCH & DEVELOPMENT COMPANY, 1001 HEALTH SCIENCES ROAD WEST, IRVINE, CA 92715, A CA COMPANY
Reel/Frame 004809/0888 →
Assignment of Assignors Interest.
May 27, 1988
From: MINASKANIAN, GEVORK; PECK, JAMES V.
To: NELSON RESEARCH & DEVELOPMENT CO., A COMPANY OF CA.
Reel/Frame 004900/0645 →
Assignment of Assignors Interest.
May 27, 1988
From: MINASKANIAN, GEVORK; PECK, JAMES VAN OLDEN
To: NELSON RESEARCH & DEVELOPMENT CO.
Reel/Frame 004892/0602 →
Assignment of Assignors Interest.
Sep 26, 1988
From: HORN, ALAN S.
To: NELSON RESEARCH & DEVELOPMENT CO., 1001 HEALTH SCIENCES RD., WEST, IRVINE, CA 92715 A CORP. OF CA
Reel/Frame 004951/0826 →
Assignment of Assignors Interest.
Jan 27, 1989
From: PECK, JAMES V.; MINASKANIAN, GEVORK
To: NELSON RESEARCH & DEVELOPMENT CO.
Reel/Frame 005046/0303 →
Change of Name 9/12/89 California
Oct 18, 1989
From: NELSON RESEARCH AND DEVELOPMENT COMPANY
To: WHITBY RESEARCH INCORPORATED
Reel/Frame 005284/0125 →
Change of Name 3/13/90 Ca
Nov 26, 1990
From: WHITBY RESEARCH INCORPORATED, A CORP. OF CALIFORNIA
To: WHITBY RESEARCH, INC.
Reel/Frame 005556/0031 →
Assignment of Assignors Interest.
Apr 22, 1991
From: RAJADHYAKSHA, VITHAL J.
To: WHIBY RESEARCH, INC., 2801 RESERVE ST., RICHMOND, VA 23227
Reel/Frame 005670/0820 →
Change of Name
Sep 27, 2002
From: DISCOVERY THERAPEUTICS, INC.
To: ADERIS PHARMACEUTICALS, INC.
Reel/Frame 013128/0322 →